Coagulation, fibrinolysis and cardiovascular disease

被引：13

作者：

Lowe, GDO ^{[1
]}

Rumley, A ^{[1
]}

机构：

[1] Univ Glasgow, Royal Infirm, Dept Med, Haemophilia & Thrombosis Unit, Glasgow G31 2ER, Lanark, Scotland

来源：

FIBRINOLYSIS & PROTEOLYSIS | 1999年 / 13卷 / 02期

关键词：

D O I：

10.1016/S0268-9499(99)90084-X

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Plasma fibrinogen, other coagulation factors and fibrin degradation products are predictors of cardiovascular disease. We, therefore, suggest that the role of fibrinolysis in cardiovascular disease be considered within these contexts.

引用

页码：91 / 98

页数：8

共 106 条

[51] INCREASED PLATELET AGGREGATES IN VASCULAR AND NON-VASCULAR ILLNESS - CORRELATION WITH PLASMA-FIBRINOGEN AND EFFECT OF ANCROD [J].

LOWE, GDO ;

REAVEY, MM ;

JOHNSTON, RV ;

FORBES, CD ;

PRENTICE, CRM .

THROMBOSIS RESEARCH, 1979, 14 (2-3) :377-386

[52]

LOWE GDO, 1978, LANCET, V2, P698

[53]

LOWE GDO, 1988, TISSUE TYPE PLASMINO, P129

[54]

LOWE GDO, 1997, FIBRINOGEN CARDIOVAS

[55]

LOWE GDO, 1994, HAEMOSTASIS THROMBOS, P1169

[56]

LOWE GDO, 1997, RECENT ADV BLOOD COA, V7, P69

[57]

LOWE GDO, 1993, THROMB HAEMOSTASIS, V68, P763

[58]

MCDONAGH J, 1994, CURRENT MED LIT TH S, V4

[59]

MCFARLANE RG, 1977, BRIT MED BULL, V33, P183

[60]

Meade TW, 1998, LANCET, V351, P233

← 1 2 3 4 5 6 7 8 9 10 →